-
Dr. Peng Liu’s Team: A Promising Future as “Chemo-Free” Approaches Aim to Reshape First-Line Treatment Standards for Marginal Zone Lymphoma
From September 13th to 17th, the 2024 European Society for Medical Oncology (ESMO) Annual Meeting was held in Barcelona, Spain. As one of the top international conferences in the oncology field, it brought together experts and scholars from around the world to share cutting-edge research findings and discuss future development directions. At this year’s conference,…
-
Dr. Aiming Pang: The “Tianjin Model” of Autologous Hematopoietic Stem Cell Transplantation for Acute Leukemia
Autologous hematopoietic stem cell transplantation (ASCT) is a treatment option for adult acute leukemia in remission. Compared to allogeneic hematopoietic stem cell transplantation (allo-HSCT), ASCT has advantages such as no donor restrictions, absence of graft-versus-host disease (GVHD), and a lower transplant-related mortality rate. At the recent “4th Shanghai Symposium on the Clinical Application of Autologous…
-
Dr. Ou Bai: Interpreting the BTKi Consensus for Indolent Lymphomas in Greater China region丨The 5th Tianjin International Lymphoma Academic Conference
From September 6th to 8th, 2024, the 5th Tianjin International Lymphoma Academic Conference was successfully held. The conference featured 12 thematic sessions covering topics such as immunotherapy, translational research, and new drug development, creating a platform for promoting international academic exchange and collaboration. During the event, Hematology Frontier invited Dr. Ou Bai from The First…
-
Dr. He Huang and Didier Blaise: Exploring Breakthroughs in Cellular Therapy from Sino-French Perspectives
The 11th Sino-French Hematology Academic Conference, organized by the Chinese Medical Doctor Association, recently took place in Tianjin, drawing hundreds of leading experts and scholars in the field of hematology from around the world. During the conference, Hematology Frontier invited Dr. He Huang from The First Affiliated Hospital, Zhejiang University School of Medicine and Dr.…
-
JOH丨Optimizing Algorithms to Narrow the Gray Zone in Diagnosing Clinically Significant Portal Hypertension
Non-invasive tests (NITs), such as liver stiffness measurement (LSM), spleen stiffness measurement (SSM), and platelet count (PLT), have been validated for diagnosing CSPH and predicting decompensation risk. However, these methods…
-
Dr. Hongzhou Lu: Driving High-Quality Development in Infectious Disease Prevention with Innovative Productivity at the 15th Tuberculosis Oriental Forum
1. Understanding New Quality Productivity in Medicine: Key Scientific and Technological Innovations in Infectious Disease Prevention Professor Lu explains, “Across human history, breakthrough developments in every field have been driven…
Connecting Medical Expertise through Media
